07/06/2025
Live cases. Immediate insights. Excellent outcome.🌎
Endoscopy on Air 2025 brought the international endoscopy community again together for a day of clinical exchange and innovation and we have been again a part of it!
In various live cases, medical experts presented how our technologies are used in clinical practice:
🔹Kicking-off this year’s global event with live-cases broadcasted from Shanghai, with a gastric cardia SET performed by Prof. Zhou (China) with HybridKnife® T-Type and by Dr. Cai (China), showing an esophageal ESD with our HybridKnife® I-Type
🔹Four cases with our newest innovation, FiAPC® plus, for the treatment of gastric antral vascular ectasia (GAVE) utilized live by Prof. Pradeep Bhandari (UK) and Dr. May together with Dr. Mosko (Canada) and in two more video-cases performed by Prof. Alessandro Repici (Italy) and Prof. Thomas Rösch (Germany).
As Prof. Bhandari noted, the device offers a “very precise beam”, “minimal stickiness due to the improved tip design”, and “controlled ablation.”
🔹HYBRIDKnife® flex I-Type was utilized in an uPOEM by PD Dr. med. Torsten Beyna (Germany) and uESD by Prof. Roberta Maselli (Italy) during a re**al and gastric ESD, used in both conventional and saline-immersed settings performed by Prof. Repici and Prof. Bhandari, showing the benefit of HYBRIDknife® flex in an underwater environment.
🔹Prof. Daniel von Renteln (Canada) shared his experience and perspectives of the role of double ablation (margin and base post EMR ablation) with HybridAPC in reducing recurrence as part of advanced endoscopic resection strategies, during “The global debate continues”
Thank you to all speakers, moderators and viewers who made this global event a success. 💚
Which clinical moment stayed with you the most?
The new FiAPC® plus probes give physicians enhanced control during argon plasma coagulation (APC) procedures. With improved beam characteristics, minimized tissue sticking, greater flexibility, and superior suction performance, FiAPC® plus significantly optimizes APC workflow and outcomes in gastrointestinal applications.
FiAPC® plus probes will be commercially available in CE and CE-related markets from June 2025.
This content is intended for healthcare professionals only and may contain information about Erbe products that are not available in all markets. The products mentioned are not available for purchase by the general public. Please check our disclaimer or contact your local sales representative for specific information.